MMS

MMS is an award-winning, data-centric drug developer that provides proven and scientific approaches for the pharmaceutical and biotechnology industries to address complex trial data and regulatory submission challenges. With extensive industry experience and a data-driven drug development methodology, MMS serves as a valuable CRO partner, creating mandatory submissions that meet stringent regulatory standards. Operating across four continents globally, MMS boasts a 97% customer satisfaction rate and was named the world's best biotech company in the 2018 International Life Sciences Awards.